News

Published on 11 Apr 2024 on Bloomberg via Yahoo Finance

Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer

Article preview image

(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total equity value of about $4.9 billion, adding the biotech company’s immune treatments in its biggest acquisition ever.

Most Read from Bloomberg

US Sees Imminent Missile Strike on Israel by Iran, ProxiesVietnam Tycoon Lan Sentenced to Death Over $12 Billion FraudUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsRussia Destroys Largest Power Plant in Ukraine’s Kyiv RegionApple Plans to Overhaul Entire Mac Line With AI-Focused M4 Chips

Read the rest of the article
NASDAQ.CRSP price evolution
NASDAQ.VERA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, w...

Insider Monkey · via Yahoo Finance 21 Nov 2024
CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Nov 2024
CRISPR Therapeutics AG (CRSP): Among ARK Invest’s Top Stock Picks for 2024

We recently compiled a list of the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024. In th...

Insider Monkey · via Yahoo Finance 17 Nov 2024
CRISPR Therapeutics' SWOT analysis: gene editing pioneer faces casgevy launch...

CRISPR Therapeutics AG (NASDAQ:CRSP), a biotechnology company at the forefront of gene-based...

Investing.com 13 Nov 2024
Cathie Wood's Ark Sells $22M Worth Of Tesla Shares Following Blockbuster Q3...

On Thursday, Cathie Wood-led Ark Invest made a series of trades, with the most prominent being th...

Benzinga 25 Oct 2024
... Potential Rally From Analysts - ARK Next Generation Internet ETF...

On Tuesday, Cathie Wood’s Ark Invest made significant trades, with a notable sell-off in Robinhoo...

Benzinga 23 Oct 2024
Cathie Wood's Ark Invest Buys $3.95M Worth Of Amazon Stock Amid Company's...

On Monday, Cathie Wood-led Ark Invest made a significant move by purchasing shares of Amazon.com...

Benzinga 22 Oct 2024
Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 14 Oct 2024
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short...

We recently compiled a list of the 10 Worst ARK Stocks To Buy According To Short Sellers. In this...

Insider Monkey · via Yahoo Finance 29 Aug 2024
CRISPR Therapeutics AG (CRSP): Ark Invest is Bullish on This Stock Right Now

We recently compiled a list of Ark Invest Stock Portfolio: Top 10 Picks. In this article, we are...

Insider Monkey · via Yahoo Finance 26 Jul 2024

Copyright Statfolio @ 2024

Social Accounts